Mar 12, 2020
The Future of the Alzheimer's Disease Market to 2028 - Featuring 116 Company Profiles and 82 Collaborations
Mar 02, 2020
ANI Pharmaceuticals Announces FDA Approval of Memantine Hydrochloride Extended-Release Capsules
Nov 26, 2019
New Study by TauRx Shows a Minimum Dose of Hydromethylthionine Could Slow Cognitive Decline and Brain Atrophy in Mild-to-moderate Alzheimer's Disease
Sep 09, 2019
Neurotrope Announces Top-line Results From Confirmatory Phase 2 Study of Bryostatin-1 in Moderate to Severe Alzheimer's Disease
Aug 06, 2019
Alzheimer Disease Drugs, Companies, Markets, 2028
Aug 05, 2019
Neurotrope Announces Corporate Update and Reports Second Quarter 2019 Financial Results
Jul 15, 2019
Neurotrope Concludes Data Collection in Confirmatory Phase 2 Clinical Trial of Moderately Severe to Severe Alzheimer's Disease
Jul 05, 2019
Rising Cases of Alzheimer's in Geriatric Population to Propel Demand for Alzheimer's Drugs, Says TMR
Jan 29, 2019
Cognitive and Memory Enhancer Drugs Market to Garner $6.59 Bn, Globally, by 2023 at 8.6% CAGR, Says AMR
Dec 17, 2018
Neurotrope Announces Publication of Phase 2 Study of Bryostatin-1 in Moderate to Severe Alzheimer's Disease in the Journal of Alzheimer's Disease
Jul 25, 2018
At AAIC 2018, Neurotrope Presents Additional Clinical Results Showing Cognitive Improvement in Phase 2 Data Assessing Bryostatin-1 in Moderate-to-Severe Alzheimer's Patients
Jul 16, 2018
Neurotrope Announces the Initiation of Enrollment of its Confirmatory Phase 2 Trial in Alzheimer's Disease
Feb 08, 2018
Global Alzheimer Disease Research Report 2018: New Drugs, Markets and Companies - Profiles of 120 Companies Presented with 93 Collaborations
Jan 05, 2018
Neurotrope's Bryostatin Improves Cognition in Patients with Advanced Alzheimer's Disease Based on Further Analysis of Phase 2 Clinical Trial Data
Oct 03, 2017
Alzheimer's Disease Therapeutics and Diagnostics Market 2017-2027
Sep 06, 2017
Alzheimer's Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2025
Aug 09, 2017
Alzheimer's Drugs Market is Expected to Rise to US$6.4 Billion by 2025: Rising Awareness in Developing Countries to Boost Growth